Markus A. Ott is a Global Medical Technology Professional with more than twenty years successful experience in international/global commercial & non-commercial roles he has become a highly effective and creative industry leader with extensive knowledge of the healthcare market.

In recent past he lead the Global Market Access & Health Policy department at Roche Diagnostics International (CPS) and has been Global Innovation Lead for Foundation Medicine based in Switzerland. Last but not least was/is leading EMEA efforts of a highly innovative company in the Med Device space (Novocure) offering an innovative therapy in the area of brain and lung cancer. He established (opened up) the team in multiple European countries with a strong focus on implementation efforts (lead evaluations with local authorities and contract negotiations with insurance companies, etc.).

His passion are all aspects of his job but primarily Value Based Healthcare & the digitalization of our industry.

He is/has been a member of global Management teams for various companies and associations. So, Markus has been member of the Executive Board of MedTech Europe as well as the Swiss Diagnostic Association. He acted as Chair Elect and Executive Board Member of EPPOSI (European Platform for Patient's Organizations, Science & Industry). Until 2021 he chaired the HTA IVD & Value of Diagnostics Working groups @ MedTech Europe.

Finally, he is author of multiple publications as well as chair, panelist and speaker at many global conferences.

Creative, international and multi-cultural business, communications and public affairs executive, lawyer and entrepreneur with results-driven management experience in business development, corporate and public affairs, government relations, corporate social responsibility, crisis management, branding and positioning, stakeholder engagement, product and corporate marketing, across industries-- from healthcare to not-for profit. Specialties: Strategic corporate communications, corporate affairs, government relations, crisis and issues management, perception management, employee and change management communications, media relations, marketing communications, labor relations, industry engagement, corporate responsibility, compliance communications, issues advocacy, multicultural communications.
Currently working as Vice President Market Access, Latin America at Medtronic. Previously worked as Vice President of Public Affairs and Director Communications Latin America Region at Baxter, and had several managing positions at Burson-Marsteller in past.

Benjamin Gannon joined Myriad Genetics in March 2019 and is responsible for international market access, policy and advocacy.  Mr Gannon has over 20 years of European and international experience with the life sciences and biotech sector.   Before joining Myriad, he was responsible for international government affairs, policy and patient engagement with Vertex Pharmaceuticals.  In this role he established and led government affairs and patient engagement for Vertex’ operations internationally – this included support to market access strategy and regulatory policy.  Mr Gannon is a Board member of EUCOPE, the European Confederation of Pharmaceutical Industries.
Before joining Vertex, Mr Gannon was Vice President for Group Public Affairs for SCA and has held senior government affairs and policy roles with Gilead, Johnson & Johnson and GlaxoSmithKline.  He is a dual German/ UK national and holds Bachelor and Masters degrees in Biology from Southampton University  (UK) and Imperial College (UK) respectively.

Financial Analysis for Nonfinancial Managers / University of Chicago Booth School of Business 2013

Truck Park Manager 1990-1991

Sales Rep FORD /Spec Sales Rep Commercial Vehicles 1991-1995

Sales Rep KFB Extramobile GmbH /Regional Manager East Emergency Vehicles 1996-2000

Territory Manager Resuscitation Business ZOLL Medical Deutschland 2000-2008

Sales Manager Resuscitation Business ZOLL Medical Deutschland/Österreich 2008-2010

Country Manager ZOLL Medical Deutschland/Österreich/Schweiz (DACH) Temperature Management 2010-2018

Manager Temp Management Europe ZOLL Medical 2018-2019

Manager Temp Management EMEA/LATAM ZOLL Circulation 2019-….

Geschäftsführer ZOLL Medical Switzerland AG und ZOLL Medical Österreich GmbH

Prokurist ZOLL Medical Deutschland GmbH

My name is Dr. Frank Semrau, I was born and went to school in the northern part of Germany (Lüneburg near Hamburg). I studied Biology in Göttingen and got the Diploma in Biology (Biochemistry, Microbiology) at the Georg-August University of Göttingen. I conducted my thesis at the University Hospital of Göttingen, Center for Hygiene and Human Genetics and got a PhD from Georg-August University of Göttingen (Biochemistry, Medical Microbiology), as well.

I started my business career at, then, one of the 10 biggest pharmaceutical companies Pharmacia which merged with Pfizer some years later, as a Regional Manager Health Politics, dealing with Associations of Statutory Health Insurance Physicians which control ambulatory prescriptions of pharmaceuticals.
In 2004 the DRG system was introduced in Germany and I attended and supported the implementation as a Manager Health Economics/Government Affairs with Boston Scientific (Medical devices) for almost nine years, the last years as a department deputy. While I started with responsibility for all products, with growing department I specialized in vascular and cardiac medical technologies like stents, ICDs and pacemaker.
Since 2012 I am with ZOLL CMS as a Strategic Reimbursement Manager for European countries. I am responsible for European market access and reimbursement of the wearable cardioverter defibrillator (WCD) “LifeVest” with a strong focus on Germany. From this point of view I have a very broadly defined idea of MA & Reimbursement, including preparation and optimization of reimbursement applications and coding, as well as initiating support by physicians, clinical studies, guidelines, patient organizations, health economic assessments and models, HTAs, pricing, politics, PR and social opinion. Currently my main goal is the seamless protection of patients with high risk for sudden cardiac death (SCD) in and particularly outside the hospital.

MASSIMO G. BARBERIO is actually GovernmentAffairs, Policy& Health Economics Director Italy in GE Healthcare Italy He started his career working in the commercial department of a medium size pharmaceutical company, dealing with diagnostic hospital pharma products. After several assignments in marketing field for several large pharmaceutical companies, in 2007 he joined GE Healthcare, as South Europe Marketing Director for the Pharmaceutical Division.Since 2011Massimocovers the role of GovernmentAffairs, Policy& Health Economics Director Italy in GE HealthcareMedical Systems, dealing with the technological and pharmaceutical product portfolio and managing the Market Access activities in General Electric Healthcare. In his activity he managesthe Company official relationships with Institutions like Government and Parliament members, Health and University Ministry, Government Agencies, Professional Societies. He is in the staff of the Southern Europe President of GE Healthcare. He is member of the Italian Society of Clinical Radiology since 1995, and he is also part of the Italian Association of Nuclear Medicine, Massimo obtained also several academic assignments: appointed as Visiting Professor at the Radiology School of the Medicine Faculty at the Milano Bicocca University and as lecturer at the MBA courses at L. Bocconi University and Management School in Milan and at LUISS University in Rome, he is actually Visiting Professor at the Research Centre for study on Healthcare Management at the LIUC University of Castellanza and member of the steering committee and Professor atthe School of Finance and Management at Universitàdel Piemonte Orientale di Novara. He is author of several clinical and pharmacoeconomy papers published on some national and international peer reviewed journals, as the Italian Journal of Radiology and the California Management Review. He has a master’sdegree in Biology and a Master in Strategic Marketingandalso MasterinHealthcareEconomy and Management Born in Milan 60years ago,Massimo is married with Angela and they have one son, Daniele, 31years old and one daughter, Martina 27years old. He enjoys spending his time with his family and reading, and after a brilliant career as Italian major league Handball referee, actually his sport activity is limited todiscussions with friends on soccer games seen on TV.

Marcus has worked in medical devices for longer than he would care to admit. He began his career in UK hospitals as a cardiac technician. After only eight years he joined St Jude Medical as a junior member of the UK clinical operations team. Quickly promoted to the European headquarters he spent a number of years in Brussels performing various roles in clinical trials and medical affairs covering both European and International markets before crossing over to the market access team, again supporting both European and international markets. Marcus left St Jude to join Second Sight, a small company pioneering retinal implant technology. Marcus is currently the European market access head for Teleflex. He lives in Brussels with his wife and two children.

Stephanie Ibbotson heads the Market Access and Reimbursement Affairs department at Luminex Corporation.  Stephanie joined Luminex in 2015 where she developed the Strategic Marketing department.  Stephanie holds a BSc in Genetics from Western University, an MBA from Laurier University, an MPH from the University of Liverpool and is a certified management accountant.  Stephanie is passionate about healthcare reform and as the associate director of MDx for QIAGEN, worked with the provincial health systems in Canada to implement a new cervical cancer prevention program.  In her current role Stephanie is focused on building clinical utility evidence for syndromic assays to achieve value-based reimbursement coverage.

Nicolas holds a Master in Business from ESSEC (2008) and a master in History from the Sorbonne University in Paris (2005).

Having started as a consultant for Izsak Grapin & Associés in 2006 where he worked noticeably for ROCHE Pharma, he joined the Consumer Products division of L’OREAL in 2010 as a territory Manager to develop sales through the structuring and the optimization of the local distribution network. In 2012, he integrated L’OREAL Marketing team in Paris to reinforce the Matrix haircare brand in France.

After 2 years with Septodont where he managed and developed the international distribution network in the CIS Countries, he joins Echosens in 2017 where he currently works as International Sales Director for Italy, Central Europe, Russia and Eurasia.

Julya A. Zuenkova, MD, PhD, DBA has medical and healthcare administration background.

Julya Zuenkova has a PhD degree in medicine and is Doctor of Business administration applying the management best practices in healthcare.

Mrs Zuenkova’s areas of scientific and practical interests are value-based approach in healthcare, evidence-based management in medicine, strategic marketing and Market Access in MedTech. Within her career she repeatedly reached and exceed commercial goals.

Julya is a member of Council of Marking Guild Union, Society of Healthcare Management and Association of Healthcare managers in Oncology.

She’s an author of >80 scientific publications and a regular speaker at the international congresses.

Claus is a physician and electrical engineer with more than 20 years of experience in the hospital and medical device industry. He is the founder of MD squared, a Medical Consultancy for Medical Devices. MD squared’s passioned and inter-disciplinary team of experts helps you to make informed choices to optimize the value of your Medical Device during development, market introduction and throughout its life cycle. In our structured programs we help you to systematically translate clinical and regulatory requirements into differentiating Product Claims and demonstrated patient and economical benefit.

Stephen Hull is Principal and Founder of Hull Associates LLC, a specialized global reimbursement and market access consultancy. He and his firm leverage over 25 years of experience in US and global reimbursement and in-market expertise on behalf of pharma, medical device and diagnostics Clients. Prior to forming Hull Associates in 2007, he served as SVP for Global Reimbursement at AdvaMed, in Washington, D.C. and as chair of the ISPOR Medical Devices Council. Stephen holds a Master’s degree in health policy from the Johns Hopkins Bloomberg School of Public Health, and a bachelor’s degree in international relations and French from Colgate University.

Driven with the passion to health economics, I have more than 20 years of academic and industry experience in the field of healthcare. Holding various Regional and Global leadership positions, I have been working extensively within public health sector as well as pharma and medtech industry.

After six years employment at the Kalmar County Council in Sweden, I held global and regional Health Economics & Outcomes Research (HEOR) positions at AstraZeneca and BiogenIdec respectively. At Bristol Myers Squibb and Lundbeck I lead Market Access teams in Central Eastern European (CEE) and Nordic Region. In the last five years, I gained experience with the pricing &reimbursement challenges in the field of medical devices. I supported Straub Medical as Global Market Access Lead. Before that, I was Senior Sales Director responsible for HEOR at GE Healthcare.

Since 2018 I am a Professor at the Kozminski University heading Health Economics & Healthcare Management Division (HeM). I am the leader of the International Master Program Health Economics & Big Data (HEBDA) financed by the EU research grant. In October 2020, I was nominated to  the ISPOR’s Health Sciences Policy Council (HSPC). Since January 2020, I am chair elect of ISPOR Special Interest Group Digital Health as well.

My biggest strength is the market access planning for a successful pricing & reimbursement strategy. Knowledgably of HTA guidelines, DRG financing and hospital procurement pathways across EU & US settings, I will be able to advice on the optimal market entry that ensures the best differentiation of a given technology against alternative treatment options

Ernesto is the Founder and Managing Director of ValueConnected. He has over 23

years of experience leading healthcare strategies to drive access and expansion for new products, developing value propositions for both public and private stakeholders and assessing global market opportunities. He has worked for both government agencies and global healthcare companies in roles ranging from strategic marketing and new product development to health economics and reimbursement. Ernesto has led several Market Access projects across Europe, US, Middle East and Latin America. Ernesto holds an MBA from the University of Texas at Austin and is fluent in English, Spanish and Portuguese.

Luke Rogers is the Senior Director of Business Partnerships at Within3. Luke's background includes degrees in Business, Science & a Masters' in Health Economics. He's worked for almost 15 years in Life Sciences in Live Events, including Running & Moderating Advisory Boards, Investigator Meetings, Payer Panels & Large Congresses. Luke's role is to assist Life Sciences clients of all sizes and scopes to operationalize their digital strategy, particularly around Stakeholder Engagement.